Terms: = Liver cancer AND RAD51B, ENSG00000182185, 5890, RAD51L1, O15315, hREC2, R51H2, REC2, MGC34245 AND Prognosis
4 results:
1. Metastatic lymph node ratio as an important prognostic factor in advanced gallbladder carcinoma with at least 6 lymph nodes retrieved.
Wang J; Liu F; Ma W; Hu H; Li F
Langenbecks Arch Surg; 2023 Sep; 408(1):382. PubMed ID: 37770780
[TBL] [Abstract] [Full Text] [Related]
2. Proton beam therapy for hepatocellular carcinoma with bile duct invasion.
Iizumi T; Okumura T; Hasegawa N; Ishige K; Fukuda K; Seo E; Makishima H; Niitsu H; Takahashi M; Sekino Y; Takahashi H; Takizawa D; Oshiro Y; Baba K; Murakami M; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
BMC Gastroenterol; 2023 Aug; 23(1):267. PubMed ID: 37537527
[TBL] [Abstract] [Full Text] [Related]
3. LiSNet: An artificial intelligence -based tool for liver imaging staging of hepatocellular carcinoma aggressiveness.
Sun SW; Xu X; Liu QP; Chen JN; Zhu FP; Liu XS; Zhang YD; Wang J
Med Phys; 2022 Nov; 49(11):6903-6913. PubMed ID: 36134900
[TBL] [Abstract] [Full Text] [Related]
4. Gain of UBE2D1 facilitates hepatocellular carcinoma progression and is associated with DNA damage caused by continuous IL-6.
Zhou C; Bi F; Yuan J; Yang F; Sun S
J Exp Clin Cancer Res; 2018 Nov; 37(1):290. PubMed ID: 30482241
[TBL] [Abstract] [Full Text] [Related]